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Abstract— Over the last decades, nanoparticles as drug carriers 
have attracted a lot of attention as potential systems for targeted 
drug delivery. Their tunable size and properties have opened a 
wide variety of possibilities to design future drug vehicles.  
On the other hand, Polypurine Reverse Hoogsteen Hairpins 
(PPRHs) molecules are DNA hairpins bound via Hoogsteen bonds. 
The PPRHs can bind by Watson-Crick bonds to the desired DNA 
sequence. In this particular case, the PPRHs are synthetized to act 
against the survivin production, which is an antiapoptotic protein, 
so its inhibition provokes cellular apoptosis, as it has already been 
proved and reported in literature. 
In this work, a new system for targeted cancer therapy is presented 
from the combination of superparamagnetic iron oxide 
nanoparticles (SPIONs) and the PPRHs.  Monodisperse SPIONs 
are synthetized and functionalized with dopamine, hyaluronic acid 
and PPRHs. Dopamine acts as an anchor to the nanoparticle, 
whereas hyaluronic acid is a known ligand to the CD44 receptor, 
apart from preventing the SPIONs to agglomerate. The 
paramagnetic behavior of these nanoparticles, along with their 
tunable size, makes them a very promising system for future 
cancer treatments. 
 
Index Terms— 3. Nanopharmaceutics and Nanomedicine 
(NanoPharmaMed): cancer, nanoparticles, drug delivery, 
targeting. 
I. INTRODUCTION 
anotechnology has had a dramatic impact on how 
scientists see and study the world. Among many different 
fields that have been affected by nanotechnology, 
medicine is one of the most promising: new drug synthesis, or 
just new ways to deliver already commercialized ones, are the 
hot topics in a brand-new field called nanomedicine [1].  
Targeting is the term referred to the action of taking something 
directly to the place of interest. This phenomenon can be 
extremely relevant for many diseases such as cancer [2], where 
drug could be taken directly to the tumoral tissue. It is well-
known that currently used treatments have several side effects 
due to the drug effect throughout the body, even on the healthy 
parts. The objective of targeting is to eliminate all the side 
effects by making the drug to act only on the pathological  
site. To do so, an appropriate vehicle must be properly 
designed, synthesized and tested. Targeting can be done 
passively, or actively. One example of the former is that 
nanosized entities are thought to be able to accumulate in 
tumoral tissues due to the so-called Enhanced Permeability and 
Retention effect (EPR), that originates from the bigger 
fenestrations in the blood vessels surrounding the tumor, 
allowing the entrance of objects that do not enter in healthy 
tissues [3]. Although the idea sounds incredibly good, it is 
necessary to consider another major factor when preparing a 
drug carrier: the environment inside a living organism is very 
challenging and hostile, and therefore rigorous attention must 
be paid to the different circumstances that could potentially 
alter the morphology and/or composition of the carrier.  
Taking all the above-mentioned into account, there are many 
different systems that could be viable as drug nanocarriers, e.g. 
dendrimers, nanoparticles, nanotubes, vesicles, etc. [4]. 
In this work, the selected carriers have been magnetite (Fe3O4) 
nanoparticles due to their ease of synthesis, their ability to be 
functionalized with different compounds and also because of 
their superparamagnetic behavior [5].  From a pharmaceutical 
point of view, the drug carriers must have one particular 
property: they must have the same dimensions, this is, be 
monodisperse. For this reason, the synthetic route that has been 
followed is obtention of iron oxide nanoparticles coated with a 
monolayer of oleate. This synthetic route results in water 
insoluble nanoparticles, typically dispersed in chloroform, that 
are stable and present monodispersed sizes ranging from 10-20 
nm depending on the experimental conditions [6], [7]. 
The superparamagnetic behavior is also an interesting property, 
since it could be used to drive the nanoparticles throughout the 
body towards the pathological site by using an external 
magnetic field (an example of active targeting), or because 
upon accumulation, hyperthermia could be produced by an AC 
magnetic field, and thus destroying the desired tissue. Another 
advantage of this magnetism is the possibility to enhance 
contrast in magnetic resonance imaging (MRI), as it has been 
reported in literature [8]. 
However, bare nanoparticles cannot be used directly to living 
organisms. They must be biocompatible and biodegradable, and 
for this reason many opt for coating them with different 
molecules. 
One of the approaches scientists have carried out during the last 
years is to functionalize their vehicles with different polymers, 
such as polyethylene glycol (PEG) [9] or polyethyleneimine 
(PEI) [10], among many others. It is worth mentioning that, 
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besides improving biocompatibility, some of these polymers 
can act as ligands to certain receptors present in the membrane 
of tumoral cells, which would provide an additional route of 
active targeting.  
The design of the system and its functionalization must be done 
taking into consideration the structure of the active principle 
that has to be carried. In this work, the active principle are DNA 
molecules called PolyPurine Reverse Hoogsteen (PPRHs). 
These molecules consist of DNA hairpins bound by reverse 
Hoogsteen bonds that, once inside the cell nucleus, bind to 
certain DNA sequence and inhibit the transcription factor. In 
this case, the PPRHs are designed to bind via Watson-Crick 
bonds to a DNA sequence that corresponds to the formation of 
a protein called survivin. This is an antiapoptotic protein, so its 
inhibition results in cell apoptosis, as it has been reported in 
literature [11]. However, it is reported that PPRHs cannot enter 
inside the cell by themselves, so a carrier is needed to transport 
them throughout the body and also through the cell membrane. 
The interaction between the carrier and the active principle 
must be moderate. If the interaction is strong, like covalent 
bonding, the active principle will not be released, and no 
therapeutic effect will be observed. On the other hand, if the 
interaction is very weak, the active principle will be lost before 
reaching the pathological site. For this reason, non-covalent 
interactions as hydrogen bonds or electrostatic interactions are 
attractive for binding the drug to the nanoparticle. 
In this project, considering that the active principle, as a DNA 
molecule, has many different regions where these non-covalent 
interactions could be present, two systems have been proposed. 
The first one is a system consisting of the iron oxide 
nanoparticles (NPs) coated by a monolayer of dopamine (DA) 
and surrounded by hyaluronic acid (HA) and the PPRHs. While 
dopamine acts as an anchor, hyaluronic acid prevents the 
nanoparticles to agglomerate as well as it is a known ligand to 
the CD44 receptor which is present in the membrane of certain 
tumoral cells [12]. In this case, PPRHs are expected to be 
attached to the system by interactions like hydrogen bonds. The 
second system is a much simpler one, consisting only of the 
nanoparticles surrounded by the PPRHs. Iron oxide 
nanoparticles have positive charge on the surface, whereas 
PPRHs are negatively charged. Therefore, an electrostatic 
attraction is expected. 
Characterization of the obtained systems is also a challenge due 
to their complex and organic structure. High-Resolution 
Transmission Electron Microscopy images are crucial to 
observe the system during the different synthetic steps. The 
employed microscope is equipped with an Energy Dispersive 
X-ray spectrometer to obtain a primary elemental analysis of 
the samples. However, TEM is not the most appropriate 
technique to observe organic matter, since the electron beam 
burns it immediately and therefore different spectroscopies 
have been performed to get a better understanding of the 
systems’ composition. 
This work presents a new approach to carry PPRHs throughout 
the body with the use of magnetite nanoparticles. With the aim 
to make the system biocompatible, organic molecules such as 
dopamine and hyaluronic acid are part of one of the proposed 
vehicles. Binding with bare nanoparticles and the PPRHs are 
also studied to investigate different possible vehicles for future 
works. 
II. SYNTHESIS AND CHARACTERIZATION 
 
Synthesis 
All chemical compounds have been used as purchased. 
A. Synthesis of Iron Oleate complex:  
The iron oleate complex was synthetized using a modification 
of a procedure reported elsewhere [6]. 3.38 g of FeCl3·6H2O 
(Sigma-Aldrich, >99%) were dissolved in 12 ml of distilled 
water. The mixture was filtered, and the solution was added to 
a round bottom flask along with 10.98 g of sodium oleate (TCI 
Chemicals, >97%) , 42 ml of hexane (Panreac, 95%) and 24 ml 
of ethanol absolute (Panreac). The sample was heated up to 70 
ºC for 4 hours under stirring and nitrogen atmosphere. The 
resultant product was a red-brownish solution which was 
separated and cleaned three times with distilled water. The 
solution was put in a rotary evaporator to eliminate the 
remaining hexane. The sample was kept under vacuum for 72 
hours and then under nitrogen atmosphere for 23 hours. The 
resultant product was a red-brownish viscous oil that was 
preserved under nitrogen and without light exposure for future 
experiments. 
B. Synthesis of oleate-coated iron oxide nanoparticles 
Iron oxide nanoparticles coated with oleate groups were 
synthetized following a modified procedure reported in 
literature [6], [7]. In a typical experiment, 2.78 g of iron oleate 
(3 mmol) were added to a three-neck round bottom flask with 
10 ml of eicosane (Sigma-Aldrich, 99%) and 0.96 ml of oleic 
acid (Sigma-Aldrich, >99%). The mixture was heated up to 95 
ºC approximately and left at that temperature for a couple of 
minutes. Then, the sample was constantly heated up to 355 ºC 
at 3,3 ºC/min rate approximately under vigorous stirring and 
under reflux. Once the sample reached the desired temperature, 
the blackish mixture was cooled down to 50 ºC while keeping 
the reflux for three more minutes. 40 ml of acetone and 10 ml 
of hexane were added to the flask in order to precipitate the iron 
oxide nanoparticles. The sample was cleaned repeatedly with 
an acetone and hexane (4:1 volume) solution. The obtained 
nanoparticles were kept in different vials and dispersed in 
chloroform. Ethanol was used in one of the vials instead of 
chloroform to test the nanoparticles stability in this solvent. 
C. Synthesis of dopamine-hyaluronic acid (DA-HA) adduct 
201 mg of sodium hyaluronate (177kDa) were dissolved in 20 
ml of distilled water (pH at 5.3). Then, 95.4 mg of dopamine 
hydrochloride (Sigma-Aldrich, 98%) and 81 mg of EDC (N-(3-
Dimethylaminopropyl)-N’-(ethylcarbodiimide hydrochloride; 
Sigma-Aldrich) were introduced into the solution and the pH 
increased to 6.6. A drop of HCl 1M was added to reduce the pH 
down to 4-5. The sample was kept under stirring and HCl 1M 
drops were added to control the pH during the reaction. Once 
the pH did not increase, the reaction was finished. 
D. PolyPurine Reverse Hogsteen (PPRHs) molecules 
Coding-PPRHs, provided by the group of Dr Carlos Ciudad, 
were used in these experiments. To find polypyrimidine 
sequences in the target gene, Triplex-Forming Oligonucleotide 
Target Sequence Search software 
(http://utw10685.utweb.utexas.edu/tfo/) was used. BLAST 
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analyses were performed to confirm specificity of the designed 
PPRH without unintended targets. 
The PPRH was synthesized as non-modified 
oligodeoxynucleotide by Sigma-Aldrich (Madrid, Spain) (0.05 
mmol scale). The lyophilized PPRH was resuspended in sterile 
Tris-EDTA buffer (1 mM EDTA and 10 mM Tris, pH 8.0; 
AppliChem, Barcelona, Spain) and stored at -20 ºC. 
E. Formation of the system NPs-PPRHs 
200 µl of oleate-coated iron oxide nanoparticles in chloroform 
(5 mg/ml) were mixed with 200 µl of a solution of PPRHs 100 
nM. The samples were left shaking for 72 hours. The aqueous 
phase containing the system NPs-PPRHs was separated with a 
micropipette and saved in a vial. 
F. Formation of the system NPs-DA-HA 
The same volume of NPs-Oleate and DA-HA adduct were 
mixed and left at the shaker for 72h approximately to ensure the 
maximum ligand exchanging. The black aqueous solution was 
separated using a micropipette and preserved covered from 
light and in the fridge.  
G. Formation of the system NPs-DA-HA-PPRHs 
20 µl of the NPs-DA-HA solution were mixed with 0.33 ml of 
PPRHs 100 nM solution. The mixture was left at the shaker for 
72h approximately. After that period, the sample was left 
covered from light and saved in a fridge at 5ºC. 
 
Characterization 
 
The oleate-coated iron oxide nanoparticles (NPs-Oleate) and 
the systems NPs-PPRHs, NPs-DA-HA and NPs-DA-HA-
PPRHs were characterized at the Serveis Cientifico-tècnics of 
the University of Barcelona (CCiTUB) using a JEOL J2100 
(LaB6 filament) Transmission Electron Microscope (USA) 
operating at 200 kV equipped with a GATAN digital camera 
(Gatan Inc., Pleasaton, CA, USA). To analyze and process 
high-resolution TEM (HR-TEM) images, Gatan Digital 
Micrograph software was used.  
Elemental analysis was also performed inside the microscope 
with an INCA x-sight spectrometer from Oxford Instruments, 
with Si (Li) detector. Spectra acquisition was accomplished 
using the INCA Microanalysis Suite version 4.09 software. 
To characterize different samples like the adduct dopamine-
hyaluronic acid (DA-HA), UV-Vis spectroscopies were carried 
out. The used spectrophotometer is a UV-Vis Cary 100 Scan 
388 Varian using a 1 cm path length quartz cuvette. The 
absorption spectra were recorded on Perkin Elmer LAMBDA 
950 UV-Vis spectrophotometer. 
IR spectra were collected in a FT-IR Thermo Scientific 
Nicolet™ iS5 Spectrometer equipped with an iD7 ATR 
accessory. 
Fluorometry experiments were performed in a Near-IR 
Spectrofluorometer for Nanotechnology from HORIBA Jobin 
Yvon with a 450 W intense broadband cw xenon lamp and 
iHR320 emission spectrograph. Spectra were collected by 
Fluorescence computer software from HORIBA Jobin Yvon. 
In order to test the binding of PPRHs and the nanoparticles, 
electrophoretic experiments were carried out by the group of Dr 
Carlos Ciudad. The employed gel was composed by agarose 
(0.8%) and TAE buffer (Tris base, acetic acid and EDTA). 
Experiments were performed for approximately 2-3 hours at 10 
V/cm at room temperature.  
 
Cytotoxicity 
 
The cytotoxicity experiments were carried out by the group of 
Dr Carlos Ciudad. 
Cell culture 
PC3 prostate adenocarcinoma cells (ECACC) were grown in 
Ham’s F-12 medium supplemented with 7% fetal bovine serum 
(FBS, GIBCO, Invitrogen, Barcelona, Spain) and incubated at 
37 ºC in a humidified 5% CO2 atmosphere. 
 
Transfection 
Cells were plated in 35-mm-diameter dishes. The transfection 
procedure consisted in mixing the appropriate amount of PPRH 
and the different types of nanoparticles, using specific protocols 
described in the Results. As a positive control, the PPRH was 
also transfected with the cationic liposome N-[1-(2,3-
dioleoyloxy)propyl]-N,N,N-trimethylammonium 
methylsulfate (DOTAP) (Roche, Barcelona, Spain) for 15 min 
at room temperature, followed by the addition of the mixture to 
the cells. 
 
MTT assay 
Cells were plated in 35-mm-diameter dishes in F12 medium. 
After 6 days, 0.63 mM of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide and 18.4 mM of sodium succinate 
(both from Sigma-Aldrich, Madrid, Spain) were added to the 
culture medium and incubated for 3 h at 37 8C. After 
incubation, the medium was removed and the solubilization 
reagent (0.57% acetic acid and 10% sodium dodecyl sulfate in 
dimethyl sulfoxide) (Sigma-Aldrich, Madrid, Spain) was 
added. Cell viability was measured at 570 nm in a WPA S2100 
Diode Array spectrophotometer (Biochrom Ltd., Cambridge, 
UK). 
 
III. RESULTS AND DISCUSSION 
 
A. NPs-Oleate 
 
Superparamagnetic iron oxide nanoparticles coated with a 
monolayer of oleate were synthetized following a procedure 
published elsewhere [6], [7]. As it is reported, following this 
synthetic route one can obtain nanoparticles with different sizes 
depending on the thermal treatment. In Fig. 1, the results from 
this synthesis are shown. Iron oxide nanoparticles were 
successfully synthesized, with an average size of 15.1±0.8 nm. 
The as-obtained nanoparticles were dispersed in chloroform, 
where they remain stable for at least several months. This is the 
system from which the synthesis of the vehicles for the PPRHs 
start. To test stability in different solvents, NPs-Oleate were 
dispersed in a vial containing ethanol, but agglomeration of NPs 
formed rapidly and therefore this solution was discarded.  
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Fig. 1.  Iron oxide nanoparticles coated with a monolayer of oleate. a) and c) 
HR-TEM image of the NPs. b) Size distribution of the obtained nanoparticles. 
d) HR-TEM image of the NPs with the corresponding diffraction pattern, 
showing the crystallinity of the oleate-coated nanoparticles. 
 
B. Dopamine-Hyaluronic acid (DA-HA) adduct 
 
As already mentioned before, biocompatibility is crucial when 
preparing new medicines. For this reason, the agglomeration of 
Fe3O4 nanoparticles inside the organism is something that must 
be avoided at all cost. By functionalizing the nanoparticles 
surfaces with organic molecules, the possible interaction 
between the magnetite nanoparticles can be suppressed. 
Nevertheless, this surface functionalization is also relevant to 
immobilize other molecules, e.g. the active principle or ligands 
to certain receptors to make the nanoparticle to target specific 
sites. Given the aforementioned, dopamine (DA) and 
hyaluronic acid (HA) were the molecules selected to 
functionalize the surface of the iron oxide nanoparticles. As 
reported by spectroscopic studies by Chen and coworkers [13], 
dopamine is a bidentate enediol ligand that convert the under-
coordinated Fe surface sites back to a bulk-like lattice structure 
with an octahedral geometry for iron, which may result in tight 
binding of DA to iron oxide.  
To ensure that hyaluronic acid is also strongly bound to the 
dopamine and thus to the nanoparticle, an adduct between 
dopamine and hyaluronic acid has been prepared before adding 
them to the nanoparticle’s solution. In order to do so, the 
synthetic procedure reported by Vismara, E. et al [14] has been 
followed. To form a covalent bond between the dopamine’s 
amine group and the carboxylate from the hyaluronic acid, EDC 
(1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide) was used 
as a base (Fig. 2). 
 
 
Fig. 2.  Reaction to produce the adduct dopamine-hyaluronic acid (DA-HA). 
 
The employed hyaluronic acid had a molecular weight of 
177kDa, approximately. An excess of dopamine was added to 
ensure that all the carboxylate groups reacted, forming the 
corresponding amide.  
The resultant product is a transparent aqueous solution that 
turns brownish with time. UV-Vis spectroscopy and IR 
spectroscopy techniques were performed to study the resultant 
product. As observed in Fig. 3 a), the UV-Vis spectrum presents 
two bands: one at ~275 nm and another at ~225 nm. Both bands 
coincide with those reported from the absorbance of dopamine 
[15]. 
To further characterize the obtained product, an infrared 
spectroscopy was performed. The solvent was evaporated using 
a rotary evaporator, resulting in a transparent greyish gel that 
was used to obtain the IR spectrum. In Fig. 3 b), it can be seen 
that the IR spectra from the DA-HA presents the typical bands 
from hyaluronic acid and dopamine [16]. Therefore, it is 
possible to say that the adduct was properly formed under the 
employed experimental conditions. 
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Fig. 3.  a) UV-Vis spectrum of the adduct DA-HA. b) IR spectrum of the 
obtained dopamine-hyaluronic acid adduct (DA-HA). 
 
C. NPs-DA-HA 
 
To obtain the nanoparticles coated with dopamine and 
hyaluronic acid, a phase transfer was the method proposed. 
Oleate-coated nanoparticles are well dispersed in chloroform 
due to the monolayer of oleate that surrounds them. This 
solution was completely dark because of the presence of 
magnetite nanoparticles. On the other hand, the obtained DA-
HA adduct was a transparent aqueous solution.  
As dopamine binds strongly to the nanoparticle, when mixing 
the adduct with the NPs-Oleate solution, one could expect a 
ligand exchange between the oleate chains and the DA-HA 
compound. When mixing both solutions, the phase separation 
was clearly observed: the dark organic phase at the bottom 
containing the nanoparticles and the transparent aqueous phase 
above of it, containing the adduct. After mixing for 72 hours 
approximately in a shaker, the aqueous phase had turned black, 
indicating the presence of water-soluble iron oxide 
nanoparticles. By extraction with a micropipette, the aqueous 
phase was successfully separated and saved in a vial covered 
from light.  
In order to characterize the new water-soluble nanoparticles, 
several techniques were performed. 
HR-TEM images in Fig. 4 a) & b) show that the iron oxide 
nanoparticles did not suffer from any change in terms of size 
and crystallinity. Moreover, it can be observed that they arrange 
in a drop-like structure, probably because of the interaction 
between the hyaluronic acid molecules that surround the 
nanoparticles. Energy dispersive X-ray spectrum (Fig. 4 c)) 
shows high amounts of carbon from the DA-HA adduct around 
the nanoparticles. 
 
Fig. 4.  a) and b): HR-TEM images of the water-soluble NPs-DA-HA system. 
c) Energy Dispersive X-ray Spectroscopy spectrum from image b). 
 
It is worth mentioning that the solution of NPs-DA-HA is stable 
in water for more than a month, as no agglomeration is 
observed. On the contrary, the nanoparticles remain well 
dispersed in the medium, which is very important for new 
potential medicines using this kind of technology. 
After evaporating the solvent using a rotary evaporator, the 
sample was a black gel because of the presence of water. 
Thermogravimetric analysis (TGA) was performed using this 
gel to try to quantify the mass percentage of the organic matter 
that surrounded the nanoparticles. In Fig. 5, the TGA results  
are represented. As it can be observed, at 100ºC approximately 
11% of the total mass was lost. This is a clear indication that 
water was present in our sample, probably trapped by the 
hyaluronic acid network that formed around the nanoparticles. 
At temperatures between 144 ºC and 650ºC approximately, 
55% of the total mass of the system was evaporated. This fact, 
along with the water solubility of the nanoparticles, evidence 
that oleate was no longer present around the NPs.  
 
 
Fig. 5.  TGA results from the NPs-DA-HA system. 
 
a
) 
b
) 
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Along with the stability shown by the nanoparticles in water, it 
is also interesting to mention that after evaporating the solvent, 
the gel-like sample was easily re-dispersed in MiliQ water, 
reiterating that the organic matter surrounding the nanoparticles 
was soluble in water. 
 
D. NPs-DA-HA-PPRHs 
 
Hyaluronic acid provides lots of sites where non-covalent 
interactions could eventually take place. Taking into 
consideration that PPRHs are DNA molecules, it is sensible to 
think that they would interact with the NPs-DA-HA. Therefore, 
just by mixing both products one could expect that some sort of 
binding would occur. PPRHs are negatively charged and are 
functionalized with fluorescein. For this reason, in a process 
like an electrophoresis, they run towards to positive pole and it 
is possible to observe this phenomenon with a fluorescent light. 
On the other hand, if these PPRHs are bound to the NPs, the 
overall charge of the system would be neutral and therefore 
would not move in the electrophoretic gel. 
In order to test the amount of mixing time that is necessary to 
obtain a proper binding, an electrophoresis was performed. In 
Fig. 6, the results of the electrophoresis are depicted and clearly 
demonstrate that the mixing time and the amount of NPs were 
relevant in terms of PPRHs binding, as the amount of free 
PPRHs that ran through the gel decreased with larger mixing 
times and higher concentration of nanoparticles. The amount of 
PPRHs was the same in all samples (10 µl of a 10 µM solution). 
The first electrophoresis was performed at 5 ºC. To test also the 
effect of temperature in the mixing, a second electrophoresis 
was performed at room temperature (Fig. 7). After 72h of 
shaking a solution of NPs-DA-HA (10 mg/ml) and PPRHs 100 
nM at room temperature, no free PPRHs were present. 
 
 
Fig. 6.  Electrophoresis with different mixing times and different amounts of 
NPs-DA-HA. The black area at the bottom represents the quantity of free 
PPRHs present in solution. As mixing time increased, the number of free 
PPRHs molecules decreased. 
 
 
Fig. 7.  Electrophoresis demonstrating that no free PPRHs were present in 
solution after 72h of mixing at room temperature. 
 
HR-TEM images (Fig. 8) show nanoparticles surrounded by 
organic matter, similarly to those obtained in the NPs-DA-HA 
system. However, as PPRHs are DNA molecules, bases within 
the sequence are bound via phosphate groups. For this reason, 
if the organic matter observed in the TEM images contained 
PPRHs, phosphorous should be present in the Energy 
Dispersive X-ray (EDX) spectra. In Fig. 8, these TEM images 
are presented along with the corresponding EDX. As it can be 
observed, the nanoparticles present the same size than the first 
NPs-Oleate system (15 nm approximately) and they are also 
crystalline, illustrating that the magnetite core of the 
nanoparticles did not change during the functionalization 
processes. 
Moreover, as expected, EDX shows the presence of 
phosphorous, indicating that the NPs-DA-HA-PPRHs system 
was successfully synthesized. 
As commented before, PPRHs molecules are functionalized 
with fluorescein. If the organic matter that surrounded the 
nanoparticles observed in TEM images corresponded to 
polypurine molecules, they should have absorbed and emitted 
radiation due to the presence of fluorescein. In order to 
corroborate this, fluorimetry experiments were performed. So 
as to compare the effect of the concentration of fluorescein in  
the emission spectrum, highly and lowly concentrated solutions 
of fluorescein were measured, as well as the solution containing  
 
Fig. 8.  a) and b): HR-TEM images of the system NPs-DA-HA-PPRHs system. 
c) Energy Dispersive X-ray Spectroscopy spectrum from image a).The presence 
of phosphorous is a clear suggestion of the presence of PPRHs (red circle) 
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Fig. 9.  Fluorometry spectrum of different solutions of fluorescein and NPs-
DA-HA-PPRHs 
 
the nanoparticles. The results in Fig. 9 show that the solution 
NPs-DA-HA-PPRHs presented fluorescence, at approximately 
the same wavelength than the fluorescein control samples, 
remarking thus that the functionalization had actually taken 
place. 
 
E. Cytotoxicity of NPs-DA-HA-PPRHs 
 
As previously mentioned, even though PPRHs produce cell 
apoptosis, they do no have the ability to enter inside the cell by 
themselves. For this reason, a decrease in cell viability could 
mean the presence of PPRHs inside the cell. For this reason and 
to further characterize the obtained system, preliminary 
cytotoxicity experiments were carried out in 10000 PC3 
prostate adenocarcinoma cells. 
In Fig. 10, results are shown. The employed experimental 
conditions were the ones that demonstrated to be the best ones 
in Fig. 6. The mixing time was 72h and the most adequate 
amount of nanoparticles was 20 µg. In this way, different  
 
 
Fig. 10.  Viability assay results. Cell viability decreased when system NPs-DA-
HA-PPRHs was introduced.  
transfection times (30 minutes and 6h) and different amount of 
PPRHs were studied (10 µl of 100 nM and 200 nM of PPRHs). 
Cell viability decreased and presented different values 
depending on the loading of PPRHs and on the transfection 
times. These results must not be misunderstood, as they are very 
preliminary, and more experiments should be made in order to 
obtain more data and to study the best experimental conditions. 
 
F. NPs-PPRHs  
 
Even though dopamine and hyaluronic acid provide the highly 
desired biocompatibility and the hindering of NPs 
agglomeration, it is also interesting to study whether the 
structure of the PPRHs is adequate to produce a ligand 
exchange with the oleate, that is, remove the oleate from the 
NPs-Oleate system and surround the nanoparticles with the 
PPRHs. Since the iron oxide nanoparticles have a positive 
charge density on their surface and the PPRHs are negatively 
charged, an electrostatic interaction could be expected. 
A similar procedure to form the NPs-DA-HA was followed to 
try to obtain a system consisting of only nanoparticles and the 
polypurines. Same volumes of NPs-Oleate (10 mg/ml) and 
PPRHs solution (100 nM) were mixed and left shaking for 
several days at room temperature. The aqueous phase, 
transparent at the beginning of the experiment, turned whitish 
and turbulent. By phase separation with a micropipette, the 
aqueous phase was saved to analyze via TEM and EDX.   In 
Fig. 11, the results are presented. Water-soluble iron oxide 
nanoparticles surrounded by PPRHs were present in solution, 
indicating that the system NPs-PPRHs was formed. Moreover, 
the nanoparticles were crystalline and monodisperse, indicating 
that they had not suffered from any change in terms of 
morphology and composition. It could also be possible that 
oleate was not removed from the surface of the nanoparticles, 
forming a hybrid system that consists of NPs-Oleate-PPRHs.  
 
Fig. 11.  a) and b): HR-TEM images of the system NPs-PPRHs system. c) 
Energy Dispersive X-ray Spectroscopy spectrum from image a). As well as in 
the sample NPs-DA-HA-PPRHs, the presence of phosphorous is a good 
indicative of the presence of PPRHs. 
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Further experiments should be performed to optimize the 
experimental conditions and to determine the real structure of 
the resultant system. 
 
IV. CONCLUSIONS 
The objectives of this work have been successfully achieved.  
A vehicle for the PPRHs is essential to drive them towards the 
pathological site and to help them get inside the desired tissue. 
Two different vehicles have been designed, taking into 
consideration very important factors like biocompatibility and 
biodegradability, one consisting of nanoparticles, dopamine, 
hyaluronic acid and PPRHs, and the other consisting of 
nanoparticles and PPRHs. The synthetic procedures have also 
been a success, as demonstrated by different characterization 
techniques such as HR-TEM and different spectroscopies. With 
such functionalization, stable water-soluble nanoparticles have 
been obtained. Moreover, even not being in the scope of this 
work, preliminary cytotoxicity experiments were carried out, 
indicating that the system NPs-DA-HA-PPRHs decreases cell 
viability. The prospect of being able to obtain this kind of 
systems based on nanoparticles and PPRHs serves as a 
continuous spur to future research. 
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